Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel + carboplatin vs paclitaxel + carboplatin in squamous NSCLC
CTR20170814Phase 3Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in Pulmonary squamous cell carcinoma, sponsored by CSPC Pharmaceutical Group. Started Jul 2017; status: completed.
02
Drugs
paclitaxel
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on CTR20170814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170814.